Finally, we investigated how the administration of CpG-proBs affected the T follicular regulatory (Tfr) to T follicular helper (Tfh) cell ratio (Tfr/Tfh), which is key in controlling the CD4+ T-B cell interaction taking place in GVHD. The gene discussed is TFRC; the disease is graft versus host disease.